These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22788243)

  • 1. Chromosomal instability induced by mammography X-rays in primary human fibroblasts from BRCA1 and BRCA2 mutation carriers.
    Frankenberg-Schwager M; Gregus A
    Int J Radiat Biol; 2012 Nov; 88(11):846-57. PubMed ID: 22788243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
    Speit G; Trenz K
    Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.
    Narod SA; Lubinski J; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Rosen B; Kim-Sing C; Isaacs C; Domchek S; Sun P;
    Lancet Oncol; 2006 May; 7(5):402-6. PubMed ID: 16648044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
    Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
    Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage.
    Nieuwenhuis B; Van Assen-Bolt AJ; Van Waarde-Verhagen MA; Sijmons RH; Van der Hout AH; Bauch T; Streffer C; Kampinga HH
    Int J Radiat Biol; 2002 Apr; 78(4):285-95. PubMed ID: 12020440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay.
    Ernestos B; Nikolaos P; Koulis G; Eleni R; Konstantinos B; Alexandra G; Michael K
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1199-205. PubMed ID: 20206018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.
    Baeyens A; Thierens H; Claes K; Poppe B; de Ridder L; Vral A
    Int J Radiat Biol; 2004 Oct; 80(10):745-56. PubMed ID: 15799620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
    Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
    Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
    Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
    DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair.
    Arnold K; Kim MK; Frerk K; Edler L; Savelyeva L; Schmezer P; Wiedemeyer R
    Cancer Lett; 2006 Nov; 243(1):90-100. PubMed ID: 16448746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
    J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity.
    Becker AA; Graeser MK; Landwehr C; Hilger T; Baus W; Wappenschmidt B; Meindl A; Weber RG; Schmutzler RK
    Breast Cancer Res Treat; 2012 Aug; 135(1):167-75. PubMed ID: 22729890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
    Kriege M; Seynaeve C; Meijers-Heijboer H; Collee JM; Menke-Pluymers MB; Bartels CC; Tilanus-Linthorst MM; Blom J; Huijskens E; Jager A; van den Ouweland A; van Geel B; Hooning MJ; Brekelmans CT; Klijn JG
    J Clin Oncol; 2009 Aug; 27(23):3764-71. PubMed ID: 19564533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of low-filtered 30 kVp X-rays, mammography X-rays and conventional X-rays in cultured mammalian cells.
    Frankenberg-Schwager M; Garg I; Fran-Kenberg D; Greve B; Severin E; Uthe D; Göhde W
    Int J Radiat Biol; 2002 Sep; 78(9):781-9. PubMed ID: 12428919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.
    Foray N; Randrianarison V; Marot D; Perricaudet M; Lenoir G; Feunteun J
    Oncogene; 1999 Dec; 18(51):7334-42. PubMed ID: 10602489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.
    Crook T; Brooks LA; Crossland S; Osin P; Barker KT; Waller J; Philp E; Smith PD; Yulug I; Peto J; Parker G; Allday MJ; Crompton MR; Gusterson BA
    Oncogene; 1998 Oct; 17(13):1681-9. PubMed ID: 9796697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
    van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
    Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.
    Goldfrank D; Chuai S; Bernstein JL; Ramon Y Cajal T; Lee JB; Alonso MC; Diez O; Baiget M; Kauff ND; Offit K; Robson M
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2311-3. PubMed ID: 17119064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.